Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2002
12/12/2002WO2002099423A2 Method for determining an analyte
12/12/2002WO2002099422A2 Individualization of therapy with alzheimer's disease agents
12/12/2002WO2002099421A2 Specific microarrays for breast cancer screening
12/12/2002WO2002099420A1 Diagnostic method based on lipid measuring parameter modulations/effector quotient profiles
12/12/2002WO2002099419A1 Composition and method for detecting an adulterant in an aqueous sample
12/12/2002WO2002099418A1 Premalignant, serially-transplantable breast tissue lines and uses thereof
12/12/2002WO2002099417A2 Method for detecting a substance and microtiter plate
12/12/2002WO2002099410A1 Sensor device and method for indicating oxygen consumption
12/12/2002WO2002099408A1 Signal detecting sensor provided with multi-electrode
12/12/2002WO2002099398A1 Methods and apparatus for characterization of single polymers
12/12/2002WO2002099391A2 Particle probe
12/12/2002WO2002099389A1 Variable polyhedron form for manufacturing biological tissue specimen
12/12/2002WO2002099387A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/12/2002WO2002099386A2 Microcalorimetric detection of analytes and binding events
12/12/2002WO2002099383A2 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/12/2002WO2002099382A2 Multiplexing method
12/12/2002WO2002099381A2 A single-cell biosensor for the measurement of gpcr ligands in a test sample
12/12/2002WO2002099380A2 Optical red and white blood cell differentiation
12/12/2002WO2002099378A2 Methods of identifying anti-cancer agents that are inducers of apoptosis
12/12/2002WO2002099359A1 Method and device for determining the angle between two facets of a transparent object
12/12/2002WO2002099140A1 GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099138A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099124A2 Characterising polypeptides
12/12/2002WO2002099123A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099121A2 Toxicity monitor
12/12/2002WO2002099120A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002WO2002099118A2 Method of identifying a polymorphism in cyp2d6
12/12/2002WO2002099115A2 Nucleic acid-associated proteins
12/12/2002WO2002099114A2 Methods to determine prognosis after therapy for bladder cancer
12/12/2002WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002WO2002099088A1 Double-transfected cell line useful for the identification of transport inhibitors
12/12/2002WO2002099085A2 Human secreted proteins
12/12/2002WO2002099083A2 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099078A2 Functional proteomic profiling
12/12/2002WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099073A2 Method of assessing levels of infectious virus in a biological sample
12/12/2002WO2002099068A2 Lces as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099059A2 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099058A2 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099057A2 Sams modifiers of the p53 pathway and methods of use
12/12/2002WO2002099056A2 C22c7orfs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099055A2 Cips as modifiers of the p53 pathway and method of use
12/12/2002WO2002099054A2 Hccss as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099053A2 Slc22as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099052A2 Opns as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099051A2 Nits as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099050A2 Tprs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099049A2 Tbc1d1s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099048A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099047A2 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099046A2 Spo11 as modifier of the p53 pathway and methods of use
12/12/2002WO2002099044A2 B3galts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099043A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099042A2 Cads as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099041A2 Ces2s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099038A2 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099036A2 Inhibition of neurodegeneration
12/12/2002WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002WO2002098919A2 Method for apo ciii measurement in apob and non apob containing particles
12/12/2002WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098898A2 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002WO2002098891A2 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098890A2 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098889A2 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002WO2002098787A1 System for measuring water contents in oil flow and automatically controlling oil flow
12/12/2002WO2002098531A1 Methods for purifying highly anionic proteins
12/12/2002WO2002098469A1 In vivo assay for anti angiogenic compounds
12/12/2002WO2002098468A1 SLC13As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098467A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098458A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002WO2002098438A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
12/12/2002WO2002098364A2 Magnetic-nanoparticle conjugates and methods of use
12/12/2002WO2002098358A2 Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098351A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002WO2002098347A2 Methods and compositions that affect melanogenesis (pfi-016cip/pct)
12/12/2002WO2002098287A2 A high throughput biological heart rate monitor that is molecularly determined
12/12/2002WO2002098220A2 Pesticidal activity of functionalized alkenes
12/12/2002WO2002098199A2 Method and system for marking and determining the authenticity of liquid hydrocarbons
12/12/2002WO2002091286A3 Analysis and presentation of internal features of logs
12/12/2002WO2002090976A3 Disposable cup and cone used in blood analysis instrumentation
12/12/2002WO2002090964A8 Method and apparatus to determine the performance of protein arrays
12/12/2002WO2002086498A8 Systems and methods for automated analysis of cells and tissues
12/12/2002WO2002085306A3 Use of follistatin to increase muscle mass
12/12/2002WO2002083846A3 Methods of analysis and labeling of protein-protein interactions
12/12/2002WO2002083081A3 Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
12/12/2002WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002WO2002077627A3 Patch-clamping and its use in analysing subcellular features
12/12/2002WO2002077249A3 Type iii bacterial strains for use in medicine
1 ... 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 ... 3937